Integrative Sequencing in Germline and Hereditary Tumours

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Hereditary Cancer SyndromeHigh-RiskMutationGermline Mutation

Trial Locations (1)

University Health Network, Toronto

All Listed Sponsors

lead

University Health Network, Toronto

OTHER

NCT03857594 - Integrative Sequencing in Germline and Hereditary Tumours | Biotech Hunter | Biotech Hunter